BIIB021 Free base
To Order Contact us: stephen@expresspharmapulse.com
 gel casting base for evs3300 |
|
EVS3300-BASE |
Consort |
ea |
EUR 361.2 |
 BIIB021 |
|
A4058-10 |
ApexBio |
10 mg |
EUR 170.4 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-100 |
ApexBio |
100 mg |
EUR 505.2 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-5 |
ApexBio |
5 mg |
EUR 135.6 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 145.2 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-50 |
ApexBio |
50 mg |
EUR 351.6 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
 Vatalanib, Free Base |
|
2026-25 |
Biovision |
|
EUR 366 |
Vatalanib, Free Base |
|
2026-5 |
Biovision |
|
EUR 151.2 |
 Erlotinib, Free Base |
|
2048-100 |
Biovision |
|
EUR 189.6 |
Erlotinib, Free Base |
|
2048-1000 |
Biovision |
|
EUR 464.4 |
 Sunitinib, Free base |
|
2097-100 |
Biovision |
|
EUR 229.2 |
Sunitinib, Free base |
|
2097-1000 |
Biovision |
|
EUR 601.2 |
Sunitinib, Free base |
|
2097-25 |
Biovision |
|
EUR 138 |
) Ruxolitinib (free base) |
|
10-042 |
ProSci |
25 mg |
EUR 418.2 |
|
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19). |
 Lapatinib, Free base |
|
2138-100 |
Biovision |
|
EUR 464.4 |
Lapatinib, Free base |
|
2138-25 |
Biovision |
|
EUR 229.2 |
 Ruxolitinib, Free base |
|
2139-100 |
Biovision |
|
Ask for price |
Ruxolitinib, Free base |
|
2139-25 |
Biovision |
|
EUR 639.6 |
Ruxolitinib, Free base |
|
2139-5 |
Biovision |
|
EUR 248.4 |
 Imatinib, Free base |
|
2141-100 |
Biovision |
|
EUR 176.4 |
Imatinib, Free base |
|
2141-1000 |
Biovision |
|
EUR 502.8 |
 Linsitinib, Free base |
|
2294-25 |
Biovision |
|
EUR 679.2 |
Linsitinib, Free base |
|
2294-5 |
Biovision |
|
EUR 222 |
 Tipifarnib, Free base |
|
2296-1 |
Biovision |
|
EUR 170.4 |
Tipifarnib, Free base |
|
2296-5 |
Biovision |
|
EUR 496.8 |
) Rucaparib (free base) |
|
A8893-10 |
ApexBio |
10 mg |
EUR 240 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-200 |
ApexBio |
200 mg |
EUR 1243.2 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-5 |
ApexBio |
5 mg |
EUR 164.4 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 170.4 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-50 |
ApexBio |
50 mg |
EUR 547.2 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
 LY2835219 free base |
|
A3575-100 |
ApexBio |
100 mg |
EUR 686.4 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
LY2835219 free base |
|
A3575-25 |
ApexBio |
25 mg |
EUR 309.6 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
LY2835219 free base |
|
A3575-5 |
ApexBio |
5 mg |
EUR 170.4 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
) R406 (free base) |
|
A5880-100 |
ApexBio |
100 mg |
EUR 1452 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-25 |
ApexBio |
25 mg |
EUR 616.8 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-5 |
ApexBio |
5 mg |
EUR 199.2 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 316.8 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
) THZ1 (Free base) |
|
9664-25 |
Biovision |
|
EUR 1227.6 |
) MCC950 (Free base) |
|
B1031-1 |
Biovision |
|
EUR 183.6 |
MCC950 (Free base) |
|
B1031-5 |
Biovision |
|
EUR 548.4 |
) FIPI (free base) |
|
B2372-25 |
Biovision |
|
EUR 757.2 |
) Terbinafine (Free base) |
|
B2423-250 |
Biovision |
|
EUR 248.4 |
Terbinafine (Free base) |
|
B2423-50 |
Biovision |
|
EUR 144 |
) PLX5622 (free base) |
|
B2965-25 |
Biovision |
25 mg |
EUR 903.6 |
PLX5622 (free base) |
|
B2965-5 |
Biovision |
5 mg |
EUR 272.4 |
) Apatinib (Free base) |
|
B1613-25 |
Biovision |
|
EUR 496.8 |
Apatinib (Free base) |
|
B1613-5 |
Biovision |
|
EUR 170.4 |
) Carubicin (Free base) |
|
B1853-1 |
Biovision |
|
EUR 183.6 |
Carubicin (Free base) |
|
B1853-5 |
Biovision |
|
EUR 548.4 |
) R406(free base) |
|
E1KS1533 |
EnoGene |
2mg |
EUR 625.2 |
) Xylazine (free base) |
|
Q-1445.0025 |
Bachem |
25.0g |
EUR 385.2 |
|
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7] |
 RGB-286638, free base |
|
2886-25 |
Biovision |
|
EUR 907.2 |
RGB-286638, free base |
|
2886-5 |
Biovision |
|
EUR 274.8 |
) GSK-J4 (Free base) |
|
2762-5 |
Biovision |
|
EUR 314.4 |
 StemRegenin 1, Free base |
|
2642-1 |
Biovision |
|
EUR 157.2 |
StemRegenin 1, Free base |
|
2642-5 |
Biovision |
|
EUR 398.4 |
 AM-095 free base |
|
A3167-10 |
ApexBio |
10 mg |
EUR 254.4 |
|
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1]. |
AM-095 free base |
|
A3167-100 |
ApexBio |
100 mg |
EUR 964.8 |
|
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1]. |
AM-095 free base |
|
A3167-200 |
ApexBio |
200 mg |
EUR 1382.4 |
|
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1]. |
AM-095 free base |
|
A3167-5 |
ApexBio |
5 mg |
EUR 199.2 |
|
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1]. |
AM-095 free base |
|
A3167-50 |
ApexBio |
50 mg |
EUR 686.4 |
|
Description: AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 ?M for mouse or recombinant human LPA1, respectively [1]. |
 SGI-1776 free base |
|
A4192-10 |
ApexBio |
10 mg |
EUR 296.4 |
|
Description: SGI-1776 free base, N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine, is a potent ATP-competitive inhibitor of the serine/threonine family of Pim kinase, an enzyme regulating cell survival. |
SGI-1776 free base |
|
A4192-5 |
ApexBio |
5 mg |
EUR 184.8 |
|
Description: SGI-1776 free base, N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine, is a potent ATP-competitive inhibitor of the serine/threonine family of Pim kinase, an enzyme regulating cell survival. |
SGI-1776 free base |
|
A4192-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 199.2 |
|
Description: SGI-1776 free base, N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine, is a potent ATP-competitive inhibitor of the serine/threonine family of Pim kinase, an enzyme regulating cell survival. |
SGI-1776 free base |
|
A4192-50 |
ApexBio |
50 mg |
EUR 630 |
|
Description: SGI-1776 free base, N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine, is a potent ATP-competitive inhibitor of the serine/threonine family of Pim kinase, an enzyme regulating cell survival. |
SGI-1776 free base |
|
A4192-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
|
Description: SGI-1776 free base, N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine, is a potent ATP-competitive inhibitor of the serine/threonine family of Pim kinase, an enzyme regulating cell survival. |
 L-Arginine free base |
|
AB0205 |
Bio Basic |
100g |
EUR 75.78 |
|
|
 GSK J4 free base |
|
B5959-10 |
ApexBio |
10 mg |
EUR 447.6 |
|
Description: GSK J4 free base |
GSK J4 free base |
|
B5959-50 |
ApexBio |
50 mg |
EUR 1437.6 |
|
Description: GSK J4 free base |
 Staurosporine, >99% Free Base |
|
BC090-001 |
GenDepot |
1mg |
EUR 295.2 |
Staurosporine, >99% Free Base |
|
BC090-005 |
GenDepot |
5mg |
EUR 408 |
BIIB021 Free base
